Cost of childhood acute lymphoblastic leukemia care in Shanghai, China
- 18 August 2009
- journal article
- research article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 53 (4), 557-562
- https://doi.org/10.1002/pbc.22127
Abstract
Background Acute lymphoblastic leukemia (ALL) is the most common and curable malignant pediatric disease in children. In low- and middle-income countries, however, economic factors prevent many patients from receiving complete treatment, even as government and insurance entities lack complete data on the costs for ALL therapies. Here, we analyzed the overall costs for pediatric ALL therapies and their constitutive elements. Procedure All cost information was drawn from our hospital database. We analyzed the costs of 45 newly diagnosed children with ALL from May 2005 to June 2006; 20 were classified into low-risk group, 25 into medium-risk group, and all had completed the ALL-2005 protocol treatment. Forty cases were B-lineage, four were T-lineage, and one was double-lymphoid lineage. Results Average total clinic expense per person was US $3,694.58 ± 1,376.85. Average total in-hospital expense per patient was US $7,299.48 ± 6,526.39, with a large individual difference. Medicine and laboratory test costs represented 40.5% and 21.5%, respectively. Patients stayed at home or attended clinic for more than 90% of the therapy period. In-hospital and clinic constituted 66.4% and 33.6% of costs, respectively. Costs among risk groups and with/without severe complications differed significantly (P < 0.05). Thirty-month event-free survivals were 94.14% and 82.81% for the low- and medium-risk groups, respectively. Conclusion Risk group and severe complications were main factors affecting total medical costs. Average overall costs for childhood ALL in this study were less than US $11,000, with reasonable clinical results. Pediatr Blood Cancer 2009;53:557–562.Keywords
Funding Information
- Science and Technology Commission of Shanghai, China (054119566)
This publication has 7 references indexed in Scilit:
- Child health insurance coverage: a survey among temporary and permanent residents in ShanghaiBMC Health Services Research, 2008
- Long‐term outcome of childhood acute lymphoblastic leukemia treated in ChinaPediatric Blood & Cancer, 2008
- The comparison of outcome and cost of three protocols for childhood non‐high risk acute lymphoblastic leukemia in ChinaPediatric Blood & Cancer, 2008
- Pediatric Cancer in the United States: The Children's Oncology Group Epidemiology Research ProgramCancer Epidemiology, Biomarkers & Prevention, 2004
- 2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with CancerClinical Infectious Diseases, 2002
- PEDIATRIC HEMATOLOGY-ONCOLOGY OUTREACH FOR DEVELOPING COUNTRIESHematology/Oncology Clinics of North America, 2001
- The Problem of Pediatric Malignancies in the Developing WorldAnnals of the New York Academy of Sciences, 1997